NGP Capital-backed food delivery service Deliveroo was valued at $2bn as of November but a successful bid would need to be a sizeable upgrade.

Nationwide Children’s Hospital spinout Celenex could fetch as much as $452m upon completion of milestones after progressing rare disease therapies conceived at the hospital’s collaborative program with Ohio State University.

Salesforce Ventures is set to exit CRM services provider Fluido three years after backing a $3.5m round, in an acquisition by Infosys.

Despite raising a reported $118m in funding from investors including Intel, Alphabet, GE, Mitsubishi and Caterpillar, Airware has shut down.

Biocon, which owns nearly a fifth in the company thanks to a licensing agreement, is in line for an exit when Equillium lists on the Nasdaq Global Market.

Tencent and Xiaomi-backed news aggregation platform Qutoutiao floated at the foot of its range, in an IPO in which JD.com invested about $14m.

The immuno-oncology therapy developer's investors include Pfizer and Gilead Sciences, both of which contributed to a $300m round in January.

A purchase of Careem, which is currently being touted at between $2bn and $2.5bn, would allow Didi Chuxing, Rakuten, Daimler, Saudi Telecom and Al Tayyar to exit.

The connected planning software provider has raised a total of $300m from investors including Salesforce and Workday and was valued at $1.4bn in 2017.

Cancer drug developer ViraTherapeutics has been acquired by Boehringer Ingelheim, three years after the corporate led its series A round.